M. Devetten

发表

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

L. Isola, J. McGuirk, M. Schuster, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelodysplastic syndromes clinical practice guidelines in oncology.

C. Bloomfield, M. Millenson, H. Deeg, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Utility of a Prognostic Scoring System for Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia

M. Qazilbash, J. Abraham, J. Lynch, 2003, Acta Haematologica.

Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.

J. Armitage, P. Bierman, R. Bociek, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hematopoietic cell transplantation: progress and obstacles.

J. Armitage, M. Devetten, James O. Armitage, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Chronic myelogenous leukemia.

J. Radich, P. Greenberg, K. Bhalla, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit

G. Hobbs, S. Ericson, A. Sarwari, 2007, Bone Marrow Transplantation.

306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)

L. Isola, J. McGuirk, M. Schuster, 2007 .

Phase II Trial of Prochymal™ (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) and Corticosteroids as Primary Treatment for Acute Graft-Vs-Host Disease (aGVHD).

L. Isola, J. McGuirk, M. Schuster, 2006 .

A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins.

J. Yu, N. Young, J. Liu, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Use of Interferon-α in Patients with West Nile Encephalitis: Report of 2 Cases

A. Kalil, P. Fayad, A. Freifeld, 2005 .

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

J. Fay, B. Storer, J. Wingard, 2009, Blood.

Human Pharmacokinetics of AC220, a Potent and Selective Class III Receptor Tyrosine Kinase Inhibitor.

P. Zarrinkar, J. Cortes, F. Giles, 2007 .

9q34 rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia.

W. Sanger, B. Dave, P. Aoun, 2005, Cancer genetics and cytogenetics.

AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study.

H. Kantarjian, J. Cortes, G. Borthakur, 2009 .

review Hematopoietic cell transplantation: progress and obstacles

J. Armitage, M. Devetten, 2007 .

Graft-versus-host disease: how to translate new insights into new therapeutic strategies.

J. Vose, M. Devetten, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

M. Qazilbash, J. Abraham, J. Lynch, 2003, Acta Haematologica.

Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.

A. Kalil, P. Fayad, A. Freifeld, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis.

J. Yu, T. Otsuki, H. Youssoufian, 1998, Cancer research.

Hematopoietic stem cell transplantation in hematologic malignancy.

J. Armitage, M. Devetten, T. Archuleta, 2004, Panminerva medica.

NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.

Susan O'Brien, Jason Gotlib, Moshe Talpaz, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Antiretroviral medication prescribing errors are common with hospitalization of HIV-infected patients.

H. Sayles, S. Swindells, U. Sandkovsky, 2014, The Journal of antimicrobial chemotherapy.

Chronic myelogenous leukemia.

J. Radich, P. Greenberg, K. Bhalla, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

J. Vose, P. Hari, R. Gale, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia

J. Armitage, P. Bierman, R. Bociek, 2007, Clinical Cancer Research.

Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.

J. Armitage, P. Bierman, R. Bociek, 2007, Cancer genetics and cytogenetics.

Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression.

S. Kajigaya, Johnson M Liu, H. Youssoufian, 1998, Blood.

Chronic Myelogenous LeukemiaPractice Guidelines in Oncology TM

J. Radich, H. Borghaei, M. Tallman, 2009 .

Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial

J. Lynch, S. Ericson, M. Devetten, 2004, Bone Marrow Transplantation.

A Randomized, Open-Label Study of Lestaurtinib (CEP-701), an Oral FLT3 Inhibitor, Administered in Sequence with Chemotherapy in Patients with Relapsed AML Harboring FLT3 Activating Mutations: Clinical Response Correlates with Successful FLT3 Inhibition.

L. Tremmel, M. Tallman, B. Smith, 2005 .

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

J. Armitage, P. Bierman, J. Vose, 2005 .

Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.

J. Vose, F. Loberiza, M. Devetten, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.

R. Arceci, S. Gore, I. Gojo, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Firstline treatment of patients with chronicphase chronic myelogenous leukemia: progress and remaining questions

M. Devetten, 2010 .

Immune Responses in AML Patients Following Vaccination with GRNVAC1, Autologous RNA Transfected Dendritic Cells Expressing Telomerase Catalytic Subunit hTERT.

R. Collins, Jennifer A. Smith, J. Dipersio, 2009 .

Association between hyperglycemia and hospital length of stay in patients undergoing hematopoietic stem cell transplantation

P. Bierman, J. Stoner, W. Goldner, 2010 .

The Fanconi anemia complementation group C gene (FAC) suppresses transformation of mutant fibroblasts by the SV40 virus.

S. Kajigaya, J. Liu, C. Walsh, 1996, Biochemical and biophysical research communications.

Phase 1 AML Study of AC220, a Potent and Selective Second Generation FLT3 Receptor Tyrosine Kinase Inhibitor

P. Zarrinkar, J. Cortes, M. Levis, 2008 .

Effectiveness of Peripheral Blood (PB) Molecular Monitoring by Quantitative RT-PCR (Q-PCR) in Phase II Acute Promyelocytic Leukemia (APL) Trial J0422.

S. Gore, I. Gojo, M. Sekeres, 2008 .